Skip to content
OpenCapital
Get started

CBIZ CBZ Stock Issued During Period Value Acquisitions

Stock Issued During Period Value Acquisitions at other companies

The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
$510.56M—

Other financials

Income statement

See full
Revenue$848.6M+1.3%
Gross profit$226.0M-0.9%
Operating income$196.4M-1.8%
Net income$161.6M+31.6%
EPS (diluted)$2.63+37.7%

Balance sheet

See full
Cash & equivalents$177.1M+18.6%
Total debt$2.0B+2.0%
Total equity$1.9B-1.1%
Total assets$4.6B+1.0%

Cash flow

See full
Operating cash flow-$25.5M+71.1%
CapEx$3.0M-42.1%
Free cash flow-$28.5M+69.5%

Valuation

See full
Market cap$1.63B-63.7%
Enterprise value$3.44B-44.0%
P/E4.6×—
P/S0.6×-1.5×

Profitability

See full
Gross margin14.5%-0.6pp
Operating margin7.2%—
Net margin7.5%—
FCF margin8.7%+4.7pp

Returns & leverage

See full
Return on equity11.2%—
Debt / equity1.1×0.0×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by CBIZ in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueAcquisitions.

The official record: CBIZ’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about CBIZ's stock issued during period value acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CBIZ's stock issued during period value acquisitions?
CBIZ (CBZ) reported stock issued during period value acquisitions of $190K in Q3 2025.
How has CBIZ's stock issued during period value acquisitions changed year-over-year?
CBIZ's stock issued during period value acquisitions decreased by 88.8% year-over-year, from $1.7M to $190K.
What is the long-term trend for CBIZ's stock issued during period value acquisitions?
Over 3 years (2021 to 2024), CBIZ's stock issued during period value acquisitions has grown at a 349.1% compound annual growth rate (CAGR), from $10.44M to $945.56M.
What does stock issued during period value acquisitions mean?
The total fair value of common stock issued as consideration for business acquisitions during the reporting period. This indicates the extent to which the company utilizes equity rather than cash to fund inorganic growth strategies.